Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Current Liabilities | Working Capital |
---|---|---|---|
6/30/2025 | $ 221.13M | $ 31.32M | $ 189.81M |
3/31/2025 | $ 254.84M | $ 29.82M | $ 225.02M |
12/31/2024 | $ 292.72M | $ 35.96M | $ 256.77M |
9/30/2024 | $ 274.08M | $ 28.66M | $ 245.43M |
6/30/2024 | $ 299.53M | $ 38.57M | $ 260.96M |
3/31/2024 | $ 164.72M | $ 31.48M | $ 133.24M |
12/31/2023 | $ 194.24M | $ 29.82M | $ 164.42M |
9/30/2023 | $ 217.57M | $ 33.15M | $ 184.42M |
6/30/2023 | $ 242.22M | $ 35.12M | $ 207.1M |
3/31/2023 | $ 100.91M | $ 14.05M | $ 86.86M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
AssetsC - LiabilitesC
(=) Working Capital
Working Capital for TSCAN THERAPEUTICS INC is calculated as follows: AssetsC [ $ 36.45M ] - LiabilitesC [ $ 17.45M ]
(=) Working Capital [ $ 19M ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 2.78K |
---|---|
min | $ -465.2M |
max | $ 607.04M |
average | $ 96.5M |
median | $ 32.21M |
std | $ 173.86M |